Abstract

BackgroundChildren with latent tuberculosis infection (LTBI) represent a huge reservoir for future disease. We wished to determine Mycobacterium tuberculosis (M.tb) infection prevalence among BCG-immunised five-year-old children in Entebbe, Uganda, but there are limited data on the performance of immunoassays for diagnosis of tuberculosis infection in children in endemic settings. We therefore evaluated agreement between a commercial interferon gamma release assay (T-SPOT.TB) and the tuberculin skin test (TST; 2 units RT-23 tuberculin; positive defined as diameter ≥10 mm), along with the reproducibility of T-SPOT.TB on short-term follow-up, in this population.Methodology/Principal FindingsWe recruited 907 children of which 56 were household contacts of TB patients. They were tested with T-SPOT.TB at age five years and then re-examined with T-SPOT.TB (n = 405) and TST (n = 319) approximately three weeks later. The principal outcome measures were T-SPOT.TB and TST positivity. At five years, 88 (9.7%) children tested positive by T-SPOT.TB. More than half of those that were T-SPOT.TB positive at five years were negative at follow-up, whereas 96% of baseline negatives were consistently negative. We observed somewhat better agreement between initial and follow-up T-SPOT.TB results among household TB contacts (κ = 0.77) than among non-contacts (κ = 0.39). Agreement between T-SPOT.TB and TST was weak (κ = 0.28 and κ = 0.40 for T-SPOT.TB at 5 years and follow-up, respectively). Of 28 children who were positive on both T-SPOT.TB tests, 14 (50%) had a negative TST. Analysis of spot counts showed high levels of instability in responses between baseline and follow-up, indicating variability in circulating numbers of T cells specific for certain M.tb antigens.Conclusions/SignificanceWe found that T-SPOT.TB positives are unstable over a three-week follow-up interval, and that TST compares poorly with T-SPOT.TB, making the categorisation of children as TB-infected or TB-uninfected difficult. Existing tools for the diagnosis of TB infection are unsatisfactory in determining infection among children in this setting.

Highlights

  • Worldwide, tuberculosis (TB) remains one of the most important infectious causes of mortality

  • We have demonstrated a high level of instability in positive T-SPOT.TB responses between baseline and a three week follow-up and poor agreement between T-SPOT.TB and TST responses, making the categorisation of children as LTBinfected or LTB-uninfected difficult

  • Analysis of spot forming units (SFUs) showed that positive responses were not concentrated around the diagnostic test cut-off level for children whose T-SPOT.TB result varied between the first and second tests

Read more

Summary

Introduction

Tuberculosis (TB) remains one of the most important infectious causes of mortality. In 2010, there were an estimated 8.8 million incident cases and approximately 1.4 million people died from this disease [1]. A vast pool of individuals with latent tuberculosis infection (LTBI) persists in developing countries, posing a major barrier to global TB control [2]. The overall lifetime risk of LTBI reactivation is approximately 5–10% among older children and adults, but in infants and young children, the risk of progression to active disease is increased; most disease cases occur within 12 months of infection [3,4]. Infection in childhood establishes the reservoir for future epidemics, making proper diagnosis and treatment of LTBI in this vulnerable group important for TB control [5]. Children with latent tuberculosis infection (LTBI) represent a huge reservoir for future disease. We evaluated agreement between a commercial interferon gamma release assay (T-SPOT.TB) and the tuberculin skin test (TST; 2 units RT-23 tuberculin; positive defined as diameter $10 mm), along with the reproducibility of T-SPOT.TB on short-term follow-up, in this population

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call